Clinical Trials on Naevi
Total 2720 results
-
Lawson Health Research InstituteActive, not recruiting
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology... and other collaboratorsSuspended
-
Duke UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; Weill Medical College of Cornell UniversityActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Prometheus Laboratories; Key Biologics, LLC; Adelson...Active, not recruiting
-
Reata, a wholly owned subsidiary of BiogenNo longer available
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruiting
-
Mayo ClinicActive, not recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruiting
-
University of VirginiaCompletedMelanomaUnited States
-
Bristol-Myers SquibbCompletedMelanomaBrazil, Chile, United States, Ireland, Italy, Spain, Argentina, Australia, Canada, France, Mexico, New Zealand, Poland, Romania
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Terminated
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
NYU Langone HealthActive, not recruiting
-
Fondazione Melanoma OnlusWithdrawn
-
John KirkwoodBristol-Myers SquibbActive, not recruiting
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Georgetown UniversityExelixis; Hackensack Meridian Health; MedStar Franklin Square Medical CenterSuspendedMelanomaUnited States
-
Novartis PharmaceuticalsCompleted
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Genentech, Inc.CompletedMelanomaUnited States
-
University Hospital, EssenActive, not recruiting
-
Royal Free Hospital NHS Foundation TrustMerck Sharp & Dohme LLC; University College, LondonCompletedMelanoma | NeoplasmsUnited Kingdom
-
Novartis PharmaceuticalsCompleted
-
University of PennsylvaniaActive, not recruiting
-
Ludwig Institute for Cancer ResearchAustin Health; Peter MacCallum Cancer InstituteCompleted
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United KingdomCompletedMelanomaUnited Kingdom, Australia, New Zealand
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Celgene CorporationCompleted
-
M.D. Anderson Cancer CenterTerminated
-
Dana-Farber Cancer InstituteEli Lilly and CompanyActive, not recruiting
-
Istari Oncology, Inc.Duke UniversityCompleted
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States
-
University of UtahBristol-Myers Squibb; Takara Bio Inc.Terminated
-
Hellenic Cooperative Oncology GroupActive, not recruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Fondazione Melanoma OnlusCompleted
-
Bristol-Myers SquibbCompleted
-
MacroGenicsMassachusetts General HospitalTerminated
-
Radboud University Medical CenterCompleted
-
Bristol-Myers SquibbActive, not recruitingMelanomaBelgium, Luxembourg
-
M.D. Anderson Cancer CenterCompleted
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Belgium, Finland, Austria, Ireland, Sweden, Switzerland, United Kingdom, Germany, Norway
-
Northwestern UniversitySarah M. Friedewald, MD; Jennifer N. Choi, MDCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
University of California, San FranciscoMerck Sharp & Dohme LLC; OncoSec Medical IncorporatedCompleted
-
Bristol-Myers SquibbCompletedMelanomaItaly, France, Spain, Australia
-
GlaxoSmithKlineCompletedMelanomaUnited States, Spain, Germany, France, Poland, Italy, Ireland, Russian Federation